Holen Sie sich die Stockscreener-App
5.19
0.10%
0.00
Schlusskurs vom Vortag:
$5.19
Offen:
$5.22
24-Stunden-Volumen:
28,155
Relative Volume:
0.08
Marktkapitalisierung:
$244.05M
Einnahmen:
$12.60M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-10.19
EPS:
-0.5092
Netto-Cashflow:
-
1W Leistung:
+0.10%
1M Leistung:
+7.56%
6M Leistung:
+40.41%
1J Leistung:
+0.00%
1-Tages-Spanne:
$5.15
$5.22
1-Wochen-Bereich:
$4.74
$5.28
52-Wochen-Spanne:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Firmenname
Capsovision Inc
Sektor
Branche
Telefon
(408) 370-4790
Adresse
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
5.21 | 238.90M | 12.60M | -23.72M | 0 | -0.5092 |
|
ABT
Abbott Laboratories
|
110.11 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
355.57 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.66 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.67 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.31 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Roth Capital | Buy |
| 2025-07-28 | Eingeleitet | The Benchmark Company | Speculative Buy |
Capsovision Inc Aktie (CV) Neueste Nachrichten
CapsoVision to Participate in the 38th Annual ROTH Conference - Bitget
Critical Analysis: CapsoVision (CV) and Its Competitors - Defense World
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus - MSN
Reviewing CapsoVision (CV) and Its Rivals - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Update - Defense World
CapsoVision (CV) & Its Competitors Critical Contrast - Defense World
Critical Survey: CapsoVision (CV) versus Its Rivals - Defense World
Financial Review: CapsoVision (CV) & Its Peers - Defense World
Head-To-Head Contrast: CapsoVision (CV) versus Its Competitors - Defense World
Critical Contrast: CapsoVision (CV) versus Its Rivals - Defense World
Head-To-Head Comparison: CapsoVision (CV) versus The Competition - Defense World
CapsoVision (NASDAQ:CV) and Profusa (NASDAQ:PFSA) Head-To-Head Review - Defense World
CapsoVision (CV) vs. Its Competitors Financial Analysis - Defense World
Reviewing CapsoVision (CV) & Its Competitors - Defense World
Is CapsoVision (NASDAQ:CV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Contrast: CapsoVision (CV) & Its Competitors - Defense World
Contrasting CapsoVision (CV) and The Competition - Defense World
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Increases By 281.0% - MarketBeat
CapsoVision prices $27.5M IPO - MSN
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Declines By 57.4% - MarketBeat
Reviewing Perspective Therapeutics (NASDAQ:CATX) & CapsoVision (NASDAQ:CV) - Defense World
CapsoVision seeks FDA clearance for AI endoscopy module - MSN
Insider-Owned Growth Stocks Poised For Success In January 2026 - simplywall.st
CapsoVision (CV) Price Target Increased by 75.00% to 10.71 - Nasdaq
CapsoVision (NASDAQ:CV) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
CapsoVision Submits 510(k) Application for CapsoCam AI-Assisted Module - Medical Product Outsourcing
CapsoVision price target raised to $14 from $5 at Benchmark - MSN
US Smart Pills Market to Reach US$ 619.10 Million by 2033 | CAGR - openPR.com
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus - Barchart.com
CapsoVision (NASDAQ:CV) Shares Gap DownHere's Why - MarketBeat
CapsoVision, Inc.'s (NASDAQ:CV) Path To Profitability - 富途牛牛
CapsoVision Shares Rise After Company Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision (NASDAQ:CV) Shares Gap UpHere's What Happened - MarketBeat
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
CapsoVision Stock Pre-Market (-11%) : FDA 510(k) Submission for AI Module - Trefis
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
CapsoVision submits FDA application for AI-assisted capsule endoscopy By Investing.com - Investing.com Nigeria
CapsoVision submits FDA application for AI-assisted capsule endoscopy - Investing.com
CapsoVision Seeks FDA Clearance for AI Endoscopy Module - TipRanks
CapsoVision Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus® - The Manila Times
CapsoVision, Inc Submits 510(k) Application for AI Module - TradingView — Track All Markets
Certain Common Stock of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Stock Options of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Warrants of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
CapsoVision (NASDAQ:CV) Shares Down 6.5% – Time to Sell? - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Up 171.0% in December - MarketBeat
CapsoVision (NASDAQ:CV) Trading Down 6.5%Here's Why - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 12.9%Here's Why - MarketBeat
Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm
Finanzdaten der Capsovision Inc-Aktie (CV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):